Diagnosis and treatment of uterine adenomyosis: an analysis of 318 cases

In: Chinese Journal of Clinical Obstetric and Gynecology · 2001 · W2347290605
article OA: closed CC0
View on OpenAlex

Abstract

Objective To investigate the incidence, clinical characteristics, diagnosis and treatment of uterine ade-nomyosis.Methods Clinical data of 318 patients with adenomyosis confirmed by pathology from January 1997 to December 1999 admitted in our gynecological ward were analyzed retrospectively. Results The incidence of adenomyosis was 5.7% of total gynecological hospitalized patients and accounted for 20.9% among all patients hysterectomy.217/318 (68.2%) cases had dysmenor-rhea and 132 (41.5%) had menorrhagia.A hundred and ninety-two cases were diagnosed as adenomyosis preoperatively, with 60.4% diagnostic accuracy. The serum CA-125 was positive in 72.3% of patients measured. All except two patients were treated with hysterectomy. Before operation, 33 patients had received hormone treatment, e.g.gestrinone, danazol, mifepristone, estrogen, progestins or androgen, for more than three months.Dysmenorrhea was relieved in 80.0% of patients during the hormone medicine treatment, but symptoms recurred in 75.0% of cases at the first menstrual cycle after the cessation of treatment. Conclusions Hysterectomy remains the dominant treatment of adenomyosis up to now. Drugs effective for treatment of endometriosis were also effective for relief of dysmenorrhea to patients with uterine adenomyosis although the dysmenorrhea recurred rapidly when medical treatment was stopped.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosisdysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK